HERE: Health Empowerment and Resources After Pregnancy for Cardiovascular Health
This study, called HERE, is looking at ways to improve long-term heart health for women who had high blood pressure problems during pregnancy, like preeclampsia. These conditions can increase your risk of heart disease later on. The study wants to see if a "patient navigation" program can help you get the follow-up care you need after pregnancy. About 60 women who recently gave birth at Boston Medical Center (BMC) and had a high blood pressure diagnosis during pregnancy will be randomly assigned to one of two groups. One group will receive standard care, while the other will also get support from a Community Wellness Advocate (CWA) who will help with appointments and connecting you to resources. We'll be looking at how well this program works and if it's practical to use for 12 months after you give birth. The study's status is currently unclear.
- Study design
- This is an interventional study involving about 60 participants. Participants will be randomly assigned to either receive standard care or standard care plus support from a Community Wellness Advocate.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 12 months postpartum to assess the intervention's effectiveness and practicality.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
HERE: Health Empowerment and Resources After Pregnancy
At a glance
Conditions
NCT07701148
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Boston Medical Center
Boston, Massachusettsstudy coordinator listed
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Mara Murray Horwitz, MD, MPH · PRINCIPAL_INVESTIGATOR · Boston Medical Center, General Internal Medicine
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Acceptability of the intervention4-6 and 12 months postpartum
Acceptability, the perception among stakeholders that the intervention is agreeable, will be measured using the 4-item Acceptability of Intervention Measure. Responses will be collected on a 5-point Likert scale (1-5), and the total score will range from 4-20. Total score will be evaluated as a continuous outcome with higher scores indicating greater acceptability. Results will be separately analyzed among participants, navigators, and other clinical staff.
- Feasibility of the intervention4-6 and 12 months postpartum
Feasibility, the extent to which the intervention can be carried out, will be measured using the 4-item Feasibility of Intervention Measure. Responses will be collected on a 5-point Likert scale (1-5), and the total score will range from 4-20. Total score will be evaluated as a continuous outcome with higher scores indicating greater feasibility.
- Fidelity of the intervention- Penetrationmonthly for 12 months postpartum
Penetration or "reach" is defined as the percentage of eligible individuals who were screened. This fidelity related metric will be assessed using a protocol-based checklist and electronic health record data for reference monthly
- Fidelity of the intervention- Adherencemonthly for 12 months postpartum
Adherence is defined as the percentage of enrolled participants who were supported by the navigator. This fidelity related metric will be assessed using a protocol-based checklist and electronic health record data for reference monthly.